Nevertheless, in the majority of subgroups, parameters like age, CEA levels, tumor diameter, and tumor free margin seemed to influence the predictive value of GALNT14-rs62139523 “A/G” genotype for better OS and PFS in intermediate-stage CRC patients receiving surgical resection followed by 5-FU-based adjuvant chemotherapy. This evidence concerns the gene GALNT14 and neoplasm.